Your browser doesn't support javascript.
loading
The use of nanocrystalline and two other forms of calcium sulfate in the treatment of infrabony defects: A clinical and radiographic study.
Pandit, Nymphea; Sharma, Aditi; Jain, Ashish; Bali, Deepika; Malik, Rajvir; Gugnani, Shalini.
Afiliação
  • Pandit N; Department of Periodontology and Oral Implantology, DAV (C) Dental College and Hospital, Yamunanagar, Haryana, India.
  • Sharma A; Department of Periodontology and Oral Implantology, DAV (C) Dental College and Hospital, Yamunanagar, Haryana, India.
  • Jain A; Department of Periodontology and Oral Implantology, H.S Judge Institute of Dental Sciences, Chandigarh, India.
  • Bali D; Department of Periodontology and Oral Implantology, DAV (C) Dental College and Hospital, Yamunanagar, Haryana, India.
  • Malik R; Department of Periodontology and Oral Implantology, DAV (C) Dental College and Hospital, Yamunanagar, Haryana, India.
  • Gugnani S; Department of Periodontology and Oral Implantology, DAV (C) Dental College and Hospital, Yamunanagar, Haryana, India.
J Indian Soc Periodontol ; 19(5): 545-53, 2015.
Article em En | MEDLINE | ID: mdl-26644722
ABSTRACT

BACKGROUND:

Calcium sulphate(CS) is one of the oldest alloplastic graft materials used because of its biocompatibility, handling characteristics, porosity, different rates of dissolution, chemico-physical resemblance to bone mineral, ability to induce release of growth factors and potentially unlimited supply at a modest cost. Aim of the study was to evaluate the efficacy of 3 forms of calcium sulphate i.e. Nanogen (nCS)(+), BoneGen(+) and Dentogen(+) in treatment of infrabony defects and to compare their efficacy as bone grafting substitutes. MATERIALS AND

METHODS:

A prospective randomized, double blind controlled study was conducted on 45 sites from 16 subjects having Moderate to Advanced Periodontitis who were divided into 3 groups i.e. Group I (Nanogen), Group II (Dentogen) and Group III (BoneGen) clinical along with radiographic measurements were taken at baseline, 6 and 12 months postoperatively.

RESULTS:

There was no significant inter-group difference in mean clinical attachment level (CAL) values at different time intervals whereas Intra-group changes in CAL at 6 and 12 months as compared to baseline were significant statistically. In Group I, changes in CAL between 6 and 12 months were found to be statistically significant in comparison with Group II and III.

CONCLUSION:

Both Nanogen and BoneGen TR can be considered valuable options in the treatment of infra-bony periodontal defects. The faster degradation of Dentogen may negatively affect its bone regeneration potential.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2015 Tipo de documento: Article